Enliven Therapeutics To Present Updated Phase 1 ELVN-001 Data In Chronic Myeloid Leukemia At EHA 2026 And Host Investor Webcast On June 11 At 8:30 a.m. ET

Loading news article.

Enliven Therapeutics To Present Updated Phase 1 ELVN-001 Data In Chronic Myeloid Leukemia At EHA 2026 And Host Investor Webcast On June 11 At 8:30 a.m. ET | WAPE

Enliven Therapeutics To Present Updated Phase 1 ELVN-001 Data In Chronic Myeloid Leukemia At EHA 2026 And Host Investor Webcast On June 11 At 8:30 a.m. ET

Article summary

Related companies

Comments —